Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-28 Purchase |
2021-06-29 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
1,088 | $9.01 | $9,803 | 1,088 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-24 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-09-23 Option Award |
2024-09-25 4:55 pm |
N/A 2034-09-23 |
AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 9:00 pm |
N/A 2034-01-25 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:07 pm |
N/A 2033-06-30 |
AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-04-26 Option Award |
2023-04-28 4:16 pm |
N/A 2033-04-25 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
127,500 | $0 | 127,500 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 4:15 pm |
N/A 2033-02-08 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-11 4:15 pm |
N/A 2032-08-08 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-12-17 Ownership |
2022-01-07 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
1,088 | $0 | 1,248 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 4:24 pm |
N/A N/A |
AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director |
49,020 | $0 | 49,020 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 4:30 pm |
N/A 2030-12-02 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
153,600 | $0 | 153,600 (Direct) |
View |
Ownership |
2020-12-07 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
0 | $0 | 0 (Direct) |
View |